Abnormal and inconclusive findings on diagnostic imaging of breast
ICD-10 R92 is a billable code used to indicate a diagnosis of abnormal and inconclusive findings on diagnostic imaging of breast.
The ICD-10 code R92 is used to classify abnormal and inconclusive findings on diagnostic imaging of the breast, which may include mammograms, ultrasounds, or MRI scans. These findings can indicate a variety of conditions, such as benign lesions, suspicious masses, or other abnormalities that require further investigation. Common symptoms associated with these findings may include breast pain, lumps, or changes in breast shape or size. The imaging results may show calcifications, masses, or architectural distortions that are not definitively benign or malignant. It is crucial for healthcare providers to follow up with additional diagnostic procedures, such as biopsies or further imaging, to clarify the nature of the findings. Accurate coding is essential for appropriate patient management and reimbursement, as well as for tracking the incidence of breast abnormalities in the population.
Detailed documentation of patient history, imaging results, and follow-up plans is essential.
Patients presenting with breast pain or palpable masses requiring imaging.
Ensure that all imaging results are clearly documented and that any recommendations for further evaluation are noted.
Acute care documentation must include the reason for imaging and any immediate findings.
Patients presenting with acute breast symptoms, such as sudden pain or swelling.
Document any urgent follow-up needed based on imaging results to ensure continuity of care.
Used when a patient presents with abnormal findings on a screening mammogram.
Document the reason for the diagnostic mammogram and any findings.
Radiology must ensure that all imaging results are communicated to the referring physician.
R92 should be used when diagnostic imaging of the breast reveals abnormal or inconclusive findings that require further evaluation but are not definitively diagnosed as malignant.
